Stifel Financial Corp Raises Stake in Encompass Health Co. (NYSE:EHC)

Stifel Financial Corp raised its holdings in shares of Encompass Health Co. (NYSE:EHC) by 8.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 60,984 shares of the company’s stock after buying an additional 4,966 shares during the period. Stifel Financial Corp owned about 0.06% of Encompass Health worth $5,893,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of EHC. Point72 Asset Management L.P. lifted its position in Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Magnetar Financial LLC lifted its position in shares of Encompass Health by 1,176.6% during the second quarter. Magnetar Financial LLC now owns 744,836 shares of the company’s stock worth $63,899,000 after purchasing an additional 814,018 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Encompass Health by 2,302.7% in the second quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company’s stock valued at $51,780,000 after purchasing an additional 578,438 shares during the period. AQR Capital Management LLC grew its holdings in Encompass Health by 213.3% during the 2nd quarter. AQR Capital Management LLC now owns 207,202 shares of the company’s stock valued at $17,776,000 after purchasing an additional 141,075 shares in the last quarter. Finally, Cubist Systematic Strategies LLC increased its stake in Encompass Health by 762.4% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 83,347 shares of the company’s stock worth $7,150,000 after buying an additional 73,683 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of analyst reports. UBS Group upped their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Truist Financial restated a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp upped their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada raised their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, Barclays upped their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Down 0.5 %

Encompass Health stock opened at $98.19 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health Co. has a 1 year low of $65.33 and a 1 year high of $104.55. The firm’s 50-day moving average is $99.35 and its 200-day moving average is $92.55. The company has a market cap of $9.89 billion, a P/E ratio of 23.72, a PEG ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health’s revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the company posted $0.86 earnings per share. On average, equities analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.